Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Thermo Fisher Scientific; Agilent Technologies; Ontario Genomics Institute

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said this week that it has established a grant program to award life science researchers more than $400,000 in RNA-interference reagents. The firm said that the Thermo Scientific Discovery Grant Program will include various siRNA, shRNA, and microRNA reagents from its Dharmacon and Open Biosystems RNAi technology portfolios.

The firm's grant program is open to both academic and commercial researchers, who may complete an application online at www.thermo.com/RNAiDiscovery. Applications for the grants will be accepted through Sep. 7.


Agilent Technologies said this week that Cold Spring Harbor Laboratory's Dolan DNA Learning Center has adopted the firm's 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA. Agilent said that it had previously donated an analyzer to DNALC, which subsequently purchased five more of the units for its teaching labs throughout New York City.


The Ontario Genomics Institute said this week that it is funding researchers developing prognostic genetic tests for hematopoietic stem cell transplants. The institute said that it is investing in the research, which is being conducted by Jayne Danska at the Hospital for Sick Children and John Dick and Jean Wang of the University Health Network, through its Pre-Commercialization Business Development Fund.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.